COVID-19 Research Paper Volume 12, Issue 9 pp 7639—7651
Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
Figure 5. The interleukin cytokines and interferon variation trend after MERS-CoV treatment in 24 hours. (A) IL-6; (B) IL-23α; (C) IL-10; (D) IL-7; (E) IL-1α; (F) IL-1β; (G) IFN-α2; (H) IFN-2; (I) IFN-γ. (Mock: Control group; icMERS: MERS-CoV treated group).